Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
Imbalances in the kynurenine pathway (KP) of tryptophan metabolism are associated with CNS disorders, infectious diseases, autoimmune diseases and cancer, highlighting KP enzymes as potential therapeutic targets. Here, Platten and colleagues provide an overview of the physiological and pathophysiolo...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
13 February 2019
|
| In: |
Nature reviews. Drug discovery
Year: 2019, Jahrgang: 18, Heft: 5, Pages: 379-401 |
| ISSN: | 1474-1784 |
| DOI: | 10.1038/s41573-019-0016-5 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/s41573-019-0016-5 Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/s41573-019-0016-5 
|
| Verfasserangaben: | Michael Platten, Ellen A.A. Nollen, Ute F. Röhrig, Francesca Fallarino and Christiane A. Opitz |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1693114100 | ||
| 003 | DE-627 | ||
| 005 | 20230428194257.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200323s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41573-019-0016-5 |2 doi | |
| 035 | |a (DE-627)1693114100 | ||
| 035 | |a (DE-599)KXP1693114100 | ||
| 035 | |a (OCoLC)1341310672 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Platten, Michael |d 1971- |e VerfasserIn |0 (DE-588)121627780 |0 (DE-627)081431848 |0 (DE-576)261969811 |4 aut | |
| 245 | 1 | 0 | |a Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond |c Michael Platten, Ellen A.A. Nollen, Ute F. Röhrig, Francesca Fallarino and Christiane A. Opitz |
| 264 | 1 | |c 13 February 2019 | |
| 300 | |a 23 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 26.03.2020 | ||
| 520 | |a Imbalances in the kynurenine pathway (KP) of tryptophan metabolism are associated with CNS disorders, infectious diseases, autoimmune diseases and cancer, highlighting KP enzymes as potential therapeutic targets. Here, Platten and colleagues provide an overview of the physiological and pathophysiological roles of tryptophan metabolism, focusing on the clinical potential and challenges associated with targeting this pathway. | ||
| 700 | 1 | |a Opitz, Christiane |d 1979- |e VerfasserIn |0 (DE-588)132405121 |0 (DE-627)522675913 |0 (DE-576)299125041 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nature reviews. Drug discovery |d London : Nature Publ. Group, 2002 |g 18(2019), 5, Seite 379-401 |h Online-Ressource |w (DE-627)336452497 |w (DE-600)2061062-2 |w (DE-576)100800629 |x 1474-1784 |7 nnas |a Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond |
| 773 | 1 | 8 | |g volume:18 |g year:2019 |g number:5 |g pages:379-401 |g extent:23 |a Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond |
| 856 | 4 | 0 | |u https://doi.org/10.1038/s41573-019-0016-5 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.nature.com/articles/s41573-019-0016-5 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200323 | ||
| 993 | |a Article | ||
| 994 | |a 2019 | ||
| 998 | |g 132405121 |a Opitz, Christiane |m 132405121:Opitz, Christiane |d 910000 |d 911100 |e 910000PO132405121 |e 911100PO132405121 |k 0/910000/ |k 1/910000/911100/ |p 5 |y j | ||
| 999 | |a KXP-PPN1693114100 |e 3611908371 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 26.03.2020"],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title_sort":"Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond","title":"Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond"}],"relHost":[{"id":{"issn":["1474-1784"],"eki":["336452497"],"zdb":["2061062-2"]},"part":{"year":"2019","volume":"18","pages":"379-401","extent":"23","text":"18(2019), 5, Seite 379-401","issue":"5"},"titleAlt":[{"title":"Nature reviews / Drug discovery"},{"title":"Drug discovery"}],"pubHistory":["1.2002 -"],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 11.01.2019"],"title":[{"title":"Nature reviews","title_sort":"Nature reviews","partname":"Drug discovery"}],"origin":[{"publisher":"Nature Publ. Group","dateIssuedKey":"2002","dateIssuedDisp":"2002-","publisherPlace":"London"}],"disp":"Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyondNature reviews. Drug discovery","physDesc":[{"extent":"Online-Ressource"}],"recId":"336452497"}],"person":[{"family":"Platten","role":"aut","given":"Michael","display":"Platten, Michael"},{"family":"Opitz","role":"aut","given":"Christiane","display":"Opitz, Christiane"}],"origin":[{"dateIssuedDisp":"13 February 2019","dateIssuedKey":"2019"}],"physDesc":[{"extent":"23 S."}],"recId":"1693114100","id":{"eki":["1693114100"],"doi":["10.1038/s41573-019-0016-5"]},"name":{"displayForm":["Michael Platten, Ellen A.A. Nollen, Ute F. Röhrig, Francesca Fallarino and Christiane A. Opitz"]}} | ||
| SRT | |a PLATTENMICTRYPTOPHAN1320 | ||